These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9116542)

  • 1. HIV trial stopped early after good results.
    Boulton A
    BMJ; 1997 Mar; 314(7082):699. PubMed ID: 9116542
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug shows potency against HIV.
    Dent Today; 1996 May; 15(5):22, 26. PubMed ID: 9567867
    [No Abstract]   [Full Text] [Related]  

  • 3. Study shows three drugs better than two.
    AIDS Alert; 1997 Apr; 12(4):39. PubMed ID: 11364145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double protease inhibitor regimens with amprenavir show promise.
    AIDS Patient Care STDS; 1998 Apr; 12(4):317-8. PubMed ID: 11361962
    [No Abstract]   [Full Text] [Related]  

  • 5. [HIV-therapy: as early and as intensive as possible].
    Dtsch Med Wochenschr; 1997 Oct; 122(41):A27. PubMed ID: 9378051
    [No Abstract]   [Full Text] [Related]  

  • 6. Study confirms that protease inhibitor cocktail can delay HIV disease progression and death.
    Randall P
    NIAID AIDS Agenda; 1997 Mar; ():1-2. PubMed ID: 11364170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data in from first head-to-head protease inhibitor.
    AIDS Patient Care STDS; 1998 Apr; 12(4):317. PubMed ID: 11361961
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-drug therapy may mean lifelong commitment.
    AIDS Alert; 1999 Jan; 14(1):3-5. PubMed ID: 11366090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease inhibitors: major study stopped when 3-drug arm proves superior.
    AIDS Treat News; 1997 Mar; (No 266):7-8. PubMed ID: 11364247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection.
    Smith D; Berrey MM; Robertson M; Mehrotra D; Markowitz M; Perrin L; Clumeck N; Lazzarin A; Burckhardt B; Weber R; Corey L; Cooper DA
    J Infect Dis; 2000 Sep; 182(3):950-4. PubMed ID: 10950796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.
    Flandre P; Peytavin G; Meiffredy V; Saidi Y; Descamps D; Delagnes M; Brun-Vézinet F; Raffi F;
    Antivir Ther; 2002 Jun; 7(2):113-21. PubMed ID: 12212923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic and virologic response of HIV-2 infection to antiretroviral therapy.
    Clark NM; Dieng Sarr A; Sankalé JL; Kanki PJ; Kazanjian P; Winfield R; Markovitz DM
    AIDS; 1998 Dec; 12(18):2506-7. PubMed ID: 9875594
    [No Abstract]   [Full Text] [Related]  

  • 15. ACTG 320: last of the body count trials?
    PI Perspect; 1997 Mar; (No 21):7. PubMed ID: 11364215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The art of 'HAART': researchers probe the potential and limits of aggressive HIV treatments.
    Stephenson J
    JAMA; 1997 Feb; 277(8):614-6. PubMed ID: 9039864
    [No Abstract]   [Full Text] [Related]  

  • 17. New study shows efavirenz effective with d4T and 3TC.
    AIDS Alert; 1999 May; 14(5):60. PubMed ID: 11366404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-HIV agents. Indinavir--3 years and still going strong.
    TreatmentUpdate; 2000 Sep; 12(6):3-4. PubMed ID: 12132460
    [No Abstract]   [Full Text] [Related]  

  • 19. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
    Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM
    N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.
    Jankelevich S; Mueller BU; Mackall CL; Smith S; Zwerski S; Wood LV; Zeichner SL; Serchuck L; Steinberg SM; Nelson RP; Sleasman JW; Nguyen BY; Pizzo PA; Yarchoan R
    J Infect Dis; 2001 Apr; 183(7):1116-20. PubMed ID: 11237839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.